ADiTx Therapeutics Inc. (ADTX): Price and Financial Metrics

ADiTx Therapeutics Inc. (ADTX): $0.35

0.02 (-6.25%)

POWR Rating

Component Grades

Momentum

F

Stability

D

Sentiment

Quality

F

Add ADTX to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#275 of 329

in industry

ADTX Price/Volume Stats

Current price $0.35 52-week high $380.00
Prev. close $0.37 52-week low $0.34
Day low $0.34 Volume 603,858
Day high $0.37 Avg. volume 742,480
50-day MA $5.98 Dividend yield N/A
200-day MA $69.69 Market Cap 1.46M

ADTX Stock Price Chart Interactive Chart >


ADiTx Therapeutics Inc. (ADTX) Company Bio


ADiTx Therapeutics, Inc. is a preclinical stage, life sciences company which engages in the development of nucleic acid (DNA)-based technologies to minimize rejection of transplanted organs by human recipients as well as address autoimmune diseases and allergies. The firm have worldwide license for commercializing a nucleic acid-based technology, named Apoptotic DNA Immunotherapy (ADi), which utilizes a novel approach that mimics the way the body naturally induces tolerance to its own tissue. The company was founded by Leonard L. Bailey, Shahrokh Shabahang, and Amro Albanna on September 28, 2017 and is headquartered in Loma Linda, CA.


ADTX Latest News Stream


Event/Time News Detail
Loading, please wait...

ADTX Latest Social Stream


Loading social stream, please wait...

View Full ADTX Social Stream

ADTX Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year N/A
3-year N/A
5-year N/A
YTD N/A
2023 N/A
2022 N/A
2021 N/A
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!